Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier. Am J Physiol Renal Physiol 293: F501-F505, 2007. First published May 16, 2007; doi:10.1152/ajprenal.00131.2007.-This study examined the metabolism of arachidonic acid (AA) by cytochrome P-450 enzymes in isolated glomeruli and the effects of selective inhibitors of the synthesis of 20-hydroxyeicosatetraenoic acid (20-HETE) and epoxyeicosatetraenoic acids (EETs) on glomerular permeability to albumin (Palb). Glomeruli avidly produced 20-HETE, EETs, dihydroxyeicosatetraenoic acids (diHETEs), and HETEs when incubated with exogenous AA. N-hydroxy-NЈ-(4-butyl-2-methylphenyl)formamidine (HET0016; 10 M) selectively inhibited the formation of 20-HETE by 95% and increased Palb from 0.00 Ϯ 0.08 to 0.73 Ϯ 0.10 (n ϭ 43 glomeruli, 4 rats). Addition of a 20-HETE mimetic, 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid (20-5,14-HEDE; 1 M) opposed the effects of HET0016 (10 M) to increase Palb (0.21 Ϯ 0.10, n ϭ 36 glomeruli, 4 rats). Preincubation of glomeruli with exogenous AA to increase basal production of 20-HETE had a similar effect. We also examined the effect of an epoxygenase inhibitor, N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide (MSPPOH; 5 M), on Palb. MSPPOH (5 M) significantly increased Palb but had no effect on the synthesis of EETs in glomeruli incubated with AA. However, MSPPOH (5 M) selectively reduced epoxygenase activity by 50% in glomeruli incubated without added AA. Pretreatment with 8,9-EET (100 nM) attenuated the effects of MSPPOH (5 M) on Palb. These results indicate that glomeruli produce 20-HETE, EETs, diHETEs, and HETEs and that endogenously formed 20-HETE and EETs play an essential role in the maintenance of the glomerular permeability barrier to albumin. glomeruli; HET0016; N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide; glomerular permeability to albumin; 20-hydroxyeicosatetraenoic acid; epoxyeicosatetraenoic acids HYPERTENSION-AND DIABETES-INDUCED NEPHROPATHIES are the leading causes of end-stage renal disease (3, 16, 22) . Elevations in glomerular capillary pressure are thought to contribute to the development of proteinuria in these conditions (5, 6, 11, 21, 24, 31) , but the mechanisms involved are not well understood. A rise in glomerular capillary pressure may contribute to the development of renal injury by increasing the production of transforming growth factor-␤ (TGF-␤) (1, 18). TGF-␤ is now known to increase glomerular permeability to albumin (P alb ), and this is associated with a fall in the endogenous formation of 20-HETE (4). Exogenous administration of a stable 20-HETE mimetic opposes the effects of TGF-␤ to increase P alb (4). Similarly, 20-HETE has been reported to oppose the increase in P alb following administration of puromycin (12). However, it remains to be determined to what extent cytochrome P-450 (CYP) metabolites of arachidonic acid (AA) are produced by glomeruli and whether they contribute to the maintenance of the glomerular permeability barrier to albumin. Therefore, in the present study, we profiled the CYP metabolites of AA produced by isolated glomeruli in the presence and absence of added substrate. We then determined the effects of selective inhibition of the endogenous formation of 20-hydroxyeicosatetraenoic acid (20-HETE) with N-hydroxy-NЈ-(4-butyl-2-methylphenyl)formamidine (HET0016) (13) and of epoxyeicosatetraenoic acids (EETs) with N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide (MSPPOH) (26) on P alb .
HYPERTENSION-AND DIABETES-INDUCED NEPHROPATHIES are the leading causes of end-stage renal disease (3, 16, 22) . Elevations in glomerular capillary pressure are thought to contribute to the development of proteinuria in these conditions (5, 6, 11, 21, 24, 31) , but the mechanisms involved are not well understood. A rise in glomerular capillary pressure may contribute to the development of renal injury by increasing the production of transforming growth factor-␤ (TGF-␤) (1, 18) . TGF-␤ is now known to increase glomerular permeability to albumin (P alb ), and this is associated with a fall in the endogenous formation of 20-HETE (4) . Exogenous administration of a stable 20-HETE mimetic opposes the effects of TGF-␤ to increase P alb (4) . Similarly, 20-HETE has been reported to oppose the increase in P alb following administration of puromycin (12) . However, it remains to be determined to what extent cytochrome P-450 (CYP) metabolites of arachidonic acid (AA) are produced by glomeruli and whether they contribute to the maintenance of the glomerular permeability barrier to albumin. Therefore, in the present study, we profiled the CYP metabolites of AA produced by isolated glomeruli in the presence and absence of added substrate. We then determined the effects of selective inhibition of the endogenous formation of 20-hydroxyeicosatetraenoic acid with N-hydroxy-NЈ-(4-butyl-2-methylphenyl)formamidine (HET0016) (13) and of epoxyeicosatetraenoic acids (EETs) with N-methylsulfonyl-6-(2-propargyloxyphenyl)hexanamide (MSPPOH) (26) on P alb .
METHODS
General. Experiments were performed on 52 male Sprague-Dawley rats weighing between 225 and 350 g, purchased from Taconic Farms (Germantown, NY). The rats were housed in the Animal Care Facility at the Medical College of Wisconsin, which is approved by the American Association for the Accreditation of Laboratory Animal Care. The rats had free access to food and water throughout the study. All protocols were approved by the Animal Care Committee of the Medical College of Wisconsin.
Metabolism of AA in isolated glomeruli. Glomeruli were isolated from the kidneys of rats as previously described (4, 17, 19) . Aliquots of the glomeruli were incubated in 1 ml of GIBCO RPMI medium 1640 (Invitrogen, Grand Island, NY) in the presence and absence of a saturating concentration of AA (42 M; Amersham Biosciences, Piscataway, NJ) and 1 mM NADPH for 60 min at 37°C. We also determined the effects of HET0016 (10 M), an inhibitor of the synthesis of 20-HETE (13), and MSPPOH (5 and 20 M), an inhibitor of the formation of EETs (26) , on the metabolism of AA by isolated glomeruli. The incubations were stopped by acidification to pH 3.5 with formic acid, glomeruli were homogenized, and the homogenate was extracted twice with 3 ml of ethyl acetate after the addition of 2 ng of an internal standard, d
6 -20-HETE (Cayman Chemicals, Ann Arbor, MI). The organic phase was collected and dried under nitrogen. The samples were reconstituted with 50% methanol and water, and the metabolites were separated by HPLC on a Betabasic C 18 column (150 ϫ 2.1 mm, 3 m; Thermo Hypersil-Keystone, Belletonte, PA) at a flow rate of 0.2 ml/min, using an isocratic elution starting from a 51:9:40:0.01 mixture of acetonitrile-methanol-water-acetic acid for 30 min, followed by a step change to 68:13:19:0.01 acetonitrile-methanol-water-acetic acid and water for 15 min. The effluent was ionized using a negative ion electrospray, and the peaks eluting with a mass-to-charge ratio (m/z) of 319 Ͼ 301 (HETEs and EETs), 337 Ͼ 319 [dihydroxyeicosatetraenoic acids (diHETEs)], or 323Ͼ270 (internal standard) were monitored using an Applied Biosystems 3000 triple quadrupole mass spectrometer (Foster City, CA). The ratios of ion abundances in the peaks of interest versus those seen in the internal standard were determined and compared with standard curves generated over a range from 0.2 to 1.0 ng for 20-HETE and from 1.0 to 10 ng for the other metabolites. Values are expressed as picomoles of product formed per minute per milligram of protein.
Measurement of P alb. Glomeruli were isolated using the sieving method in a medium containing 5 g/dl of albumin (4, 17, 19) . P alb was determined by measuring the change in glomerular volume (⌬V) after exchange of the bath with fresh medium containing 1% albumin (4, 17, 19) . P alb was calculated as 1 Ϫ (⌬Vexperimental/⌬Vcontrol), where ⌬V control was taken as the mean change in volume measured in all glomeruli treated with vehicle. The glomeruli were subjected to seven different treatments. In group 1, the glomeruli were incubated with vehicle. In group 2, the glomeruli were treated with HET0016 (10 M). In group 3, the effects of a stable 20-HETE agonist, 20-hydroxyeicosa-5(Z),14(Z)-dienoic acid (20-5,14-HEDE; 1 M) (2, 29) on the P alb response to HET0016 (10 M) were determined. In group 4, the effects of preincubation of the glomeruli with a saturating concentration of AA (42 M) for 15 min at 37°C on the P alb response to HET0016 (10 M) were determined. In groups 5 and 6, the glomeruli were incubated with MSPPOH at concentrations of 5 and 20 M, respectively. In group 7, the effects of 8,9-EET (100 nM) on the P alb response to MSPPOH (5 M) were determined. A minimum of five glomeruli from each rat were studied, and these experiments were performed using a minimum of three different rats per treatment group.
Statistical methods. Data are means Ϯ SE. Significance of differences in mean values was determined using an unpaired t-test and one-way ANOVA followed by Dunn's post hoc test. A P value Ͻ0.05 was considered to be statistically significant.
RESULTS
Glomerular metabolism of AA. Glomeruli incubated with a saturating concentration of AA (42 M) produced large peaks with a m/z of 319 and retention times corresponding to 20-HETE, 15-HETE, 12-HETE, 8-HETE, 5-HETE, 14,15-EET, 11,12-EET, and 8,9-EET, as well as peaks with a m/z of 337 with retention times corresponding to 14,15-diHETE, 11,12-diHETE, and 8,9-diHETE ( Fig. 1, A and B) . The largest peak, which eluted at 19 min, produced secondary ions following fragmentation at m/z of 301, 275, 273, 257, and 245. This pattern is identical to the tandem mass spectrometry (MS/MS) spectrum generated using a 20-HETE standard. Glomeruli incubated in the absence of exogenous AA also produced a similar profile of metabolites, but the rate of the production of 20-HETE and the other metabolites was 10 -100 times lower than that seen when glomeruli were incubated in the presence of AA (Fig. 2) .
Effects of HET0016 on the metabolism of AA in isolated glomeruli and on P alb . HET0016 (10 M) selectively reduced the synthesis of 20-HETE by Ͼ95% and had no effect on the formation of EETs, diHETEs, and HETEs in glomeruli incubated in the presence of exogenous AA (Fig. 3A) . HET0016 significantly increased P alb from 0.00 Ϯ 0.08 to 0.73 Ϯ 0.10 ( Fig. 3B) .
Effects of a 20-HETE agonist and exogenous AA on the P alb response to HET0016. The results of these experiments are presented in Fig. 4 . Addition of the stable 20-HETE mimetic 20-5,14-HEDE (1 M) had no effect on baseline P alb , but it attenuated the increase in P alb produced by HET0016 by Ͼ70% (Fig. 4A) . Similar results were obtained when the glomeruli were preincubated with AA to stimulate the endogenous formation of 20-HETE before the addition of HET0016 (Fig. 4B) .
Effects of MSPPOH on P alb and the metabolism of AA in isolated glomeruli. MSPPOH at concentrations of 5 and 20 M significantly increased P alb from 0.00 Ϯ 0.06 to 0.61 Ϯ 0.14 and 0.65 Ϯ 0.09, respectively (Fig. 5A) . Preincubation of glomeruli with 8,9-EET reduced the increase in P alb in response to MSPPOH (5 M). MSPPOH at a concentration of 20 M reduced the formation of EETs and 20-HETE by ϳ60% in glomeruli incubated with exogenous AA, but it was not effective at a concentration of 5 M (Fig. 5B) . In glomeruli incubated without exogenous substrate, 5 M MSPPOH selectively decreased epoxygenase activity by 50% (Fig. 5C ).
DISCUSSION
Previous studies indicated that induction of the renal formation of 20-HETE with fibrates or following the introgression of the CYP4A region chromosome 5 of normotensive rats into the genetic background of Dahl S rats reduces the degree of renal injury and proteinuria during the development of hypertension (7, 14, 20, 25, 27, 28) . Moreover, our laboratory recently provided evidence that the increase in P alb produced by TGF-␤ is associated with a fall in the glomerular production of 20-HETE, and preventing the fall in 20-HETE levels by administration of 20-HETE or a stable 20-HETE mimetic, 20-5,14-HEDE (2, 29), opposes the effects of TGF-␤ to increase P alb (4) . Similarly, 20-HETE has been reported to oppose the increase in P alb produced by puromycin (12) . All of these studies suggest that 20-HETE may have a protective role on the glomerular permeability barrier to oppose the development of a proteinuria and glomerular disease (4, 12) . However, the role of 20-HETE that is endogenously produced by the glomerulus in the regulation of the glomerular filtration barrier is unknown and was the focus of the present study.
Isolated glomeruli incubated with exogenous AA produced 19-and 20-HETE, along with lesser quantities of 15-, 12-, 8-, and 5-HETE. The glomeruli also produced detectable amounts of 14,15-, 11,12-, and 8,9-EETs, but the levels were quite low compared with the other metabolites formed. Nearly all of the epoxygenase metabolites appeared as diols rather than the epoxides. These results are consistent with the view that soluble epoxide hydrolase is highly expressed in kidney (30) . The profile of metabolites were similar when glomeruli were incubated without added substrate, but the rate of production was 10 to 100 times less than when the glomeruli were incubated in the absence of exogenous AA. This finding indicates that isolated glomeruli normally produce 20-HETE and EETs and that the production of these compounds is limited by the turnover of phospholipids and the availability of free AA.
The present finding that 20-HETE is the major CYP metabolite of AA produced by isolated rat glomeruli of the rat is consistent with previous observations that mRNA for the CYP4A1, -2, -3, and -8 isoforms are expressed in microdissected glomeruli and that the expression of CYP4A protein in the glomerulus is almost as high as that found in the proximal tubule and higher than the expression in renal microvessels (9, 10) .
We next evaluated the importance of endogenously formed 20-HETE in the regulation of P alb . HET0016 (10 M) selectively inhibited the formation of 20-HETE by isolated glomeruli and markedly increased P alb . Preventing the fall in 20-HETE levels in the glomerulus by adding a 20-HETE mimetic attenuated the effects of HET0016 to increase P alb . Preincubation of the glomeruli with AA, to increase the production and tissue levels of 20-HETE, also reduced the ability of HET0016 to increase P alb . These experiments indicated that the effects of HET0016 on P alb is due to a fall in the levels of 20-HETE in the glomerulus and not to a nonspecific effect of this compound. Overall, these results are the first to indicate that the sustained production of 20-HETE in the glomerulus is required to maintain the glomerular permeability barrier to albumin. We were a bit surprised that such a high concentration of HET0016 was needed to inhibit 20-HETE production in these experiments, since the reported IC 50 for this compound to inhibit 20-HETE production in rat renal microsomes is 35 nM (13) . However, in follow-up experiments, we determined using mass spectrometry that HET0016 is Ͼ98% bound to the albumin used to isolate the glomeruli and measure P alb .
Additional experiments were performed to examine the role of the endogenous production of epoxygenase metabolites in the regulation of P alb . MSPPOH increased P alb by about the same extent as HET0016. At a concentration of 20 M, this compound reduced the formation of both EETs and 20-HETE in glomeruli incubated with AA by ϳ60%. However, at the lower concentration it had no effect on the formation of EETs or 20-HETE. These findings are consistent with previous reports indicating that MSPPOH is a competitive inhibitor of epoxygenase activity with an IC 50 of ϳ13 M. At higher concentrations, it also competes for the metabolism of AA by other enzymes and inhibits the formation of 20-HETE (26) .
Additional experiments were performed to try to understand why the low concentration of MSPPOH increased P alb apparently without inhibiting epoxygenase activity in glomeruli incubated with exogenous AA. Since MSPPOH is a competitive inhibitor of the metabolism of AA, and P alb was measured in the absence of exogenous AA, we wondered whether MSPPOH might inhibit epoxygenase activity in glomeruli that were incubated in the absence of exogenous substrate when the free AA concentration was low. Under these conditions, MSPPOH (5 M) selectively reduced the formation of EETs and DiHETEs by 50% (Fig. 5C ). The addition of exogenous 8,9-EET attenuated the effects of MSPPOH (5 M) to increase P alb . This suggests the effects of MSPPOH on P alb are due to its ability to lower the levels of EETs in the glomerulus and not to a nonspecific effect of this inhibitor. Overall, these data suggest that EETs or diHETEs are also produced by the glomerulus and that they normally contribute to the regulation of P alb .
The cell types in the glomerulus that express CYP enzymes and produce EETs and 20-HETE and the mechanisms by which these products influence the glomerular protein permeability barrier remain to be determined. Possible mechanisms include changes in the shape of podocytes or capillary endothelial cells, phosphorylation or dephosphorylation of proteins such as nephrin and podocin in podocytes to alter the size of the slit pores, or changes in the phosphorylation state of ICAM and other proteins important for adherence of the foot processes of podocytes to the glomerular basement membrane. In this regard, 20-HETE has been reported to activate the PKC and MAPK signaling pathways in renal arteries (23) . Nowicki et al. (15) demonstrated that 20-HETE inhibits Na ϩ ,K ϩ -ATPase in the proximal tubule by activating the PKC pathway. Likewise, Imig et al. (8) and others have demonstrated that EETs dilate the afferent arteriole through activation of the cAMP-PKA signaling pathway, which is also known to alter P alb . Thus 20-HETE and EETs activate many signaling pathways that have been shown to influence the function of podocytes and the glomerular permeability barrier to albumin. Further work is needed to determine the pathways involved now that it is clear that these compounds play a key role as autocrine factors in the regulation of P alb .
Perspectives
Previous studies have indicated that increasing the renal formation of 20-HETE and/or EETs protects against the development of hypertension-induced proteinuria and glomerular disease (7, 14, 20, 25, 27, 28) and that exogenous administration of 20-HETE opposes the effects of TGF-␤ and puromycin to increase P alb (4, 12) . The present results now extend these findings and indicate that glomeruli normally produce 20-HETE, EETs, diHETEs, and other HETEs and that the endogenous formation of both 20-HETE and EETs plays an essential role in the maintenance of the glomerular permeability barrier to albumin.
GRANTS

